Find us on facebook youtube
No.001 February 2012 

Welcome to IVF-Today, our monthly FREE newsletter in Thai and English for health care professionals!

  • It will keep you updated with recent publications in leading international journals and highlights from recent conferences and workshops in the ever-growing topics of Reproductive Medicine, Human Embryology and Assisted Reproductive Technologies (ART).
  • Each issue will bring you news and views on issues which are relevant to the practice of ART in Thailand and South-East Asia, as well as alert you about upcoming events, conferences and educational opportunities in our field.
  • IVF-Today will also update you on The Kullapat Medical Polyclinic medical services for infertility and antenatal care, special treatment packages and how you can refer patients to us and actively participate in their work-up and treatment.
 

You can receive IVF-Today by Post or by Email, just fill in the form.

Sincerely yours,
Teraporn Vutyavanich, M.D.
Director, The Kullapat Center for ART
Chief, Division of Reproductive Medicine, Chiang Mai University

 


How effective is in vitro fertilization, and how can it be improved?

Stewart LM, et al. Fertil Steril in press 2011

IVF effectiveness could be improved if women, particularly those over 35, underwent more cycles

 

 

 

 

 


 

Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization cycles: a randomized, double-blind, placebo-controlled trial

Lamb JD, et al. Fertil Steril in press 2011

Improvements in IVF success rates have largely been due to optimization of embryo culture and stimulation protocols; less attention has been directed toward methods to improve induction of final oocyte maturation. This was the first randomized, double-blind, placebo-controlled trial to modify the ovulation trigger to improve oocyte competence, as demonstrated by the statistically significant improvement in fertilization.

 


 

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study

Chiu RWK, et al. BMJ Online First 2011;342:c7401

Multiplexed maternal plasma DNA sequencing analysis could be used to rule out fetal trisomy 21 among high risk pregnancies. If referrals for amniocentesis or chorionic villus sampling were based on the sequencing test results, about 98% of the invasive diagnostic procedures could be avoided

 

 


 

Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis

Liebaers I, et al. Human Reproduction, Vol.25, No.1 pp. 275–282, 2010

Embryo biopsy does not add risk factors to the health of singleton children born after PGD or PGS. The perinatal death rate in multiple pregnancies is such that both caution and long-term follow-up are required.